FindMyKOL

Abirami Sivapiragasam, MD

Enriched profile

Director of Medical Oncology and Associate Professor of Medicine, MUSC Hollings Cancer Center · MUSC Hollings Cancer Center

ORCIDNone on fileNPI↗
✓ Itemized profile
Region🇺🇸 Syracuse, NY · Northeast · United StatesSpecialtyHematology / OncologyFocusOncology
Active KOLLatest publicationNone indexedOnline presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Abirami Sivapiragasam is Director of Medical Oncology and Associate Professor of Medicine, MUSC Hollings Cancer Center at MUSC Hollings Cancer Center. ClinicalTrials.gov lists 1 registered study with this person as an investigator.

Data verified 8 Nov 2026

Overview

Updated 17 Nov 2026

Abirami Sivapiragasam, MD, is Director of Medical Oncology and Associate Professor of Medicine, MUSC Hollings Cancer Center. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 13 companies.

  • Top research focus: Oncology
  • 1 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 13 companies

Generated from the cited public record · current as of 17 Nov 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Breast Cancer1 trial

Research focus

OpenAlex concept fingerprint
Oncology

Drugs & molecules

across trials, industry payments and publications
KADCYLAgeneric · TrastuzumabClinical trials—Industry payments16Publications—Perjetageneric · PertuzumabClinical trials—Industry payments6Publications—Phesgogeneric · Hyaluronidase / pertuzumab / trastuzumabClinical trials—Industry payments6Publications—Trodelvygeneric · SacituzumabClinical trials—Industry payments3Publications—Itovebigeneric · InavolisibClinical trials—Industry payments2Publications—Erleadageneric · ApalutamideClinical trials—Industry payments1Publications—Fotivdageneric · TivozanibClinical trials—Industry payments1Publications—Ibrancegeneric · PalbociclibClinical trials—Industry payments1Publications—Keytrudageneric · PembrolizumabClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
AstraZeneca Pharmaceuticals LPClinical trials—Industry payments8Genentech USA, Inc.Clinical trials—Industry payments8Gilead Sciences, Inc.Clinical trials—Industry payments3Bayer Healthcare Pharmaceuticals Inc.Clinical trials—Industry payments2Daiichi Sankyo Inc.Clinical trials—Industry payments2Tempus AI, IncClinical trials—Industry payments2AVEO Pharmaceuticals, Inc.Clinical trials—Industry payments1Caris MPI, Inc.Clinical trials—Industry payments1E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments1Janssen Biotech, Inc.Clinical trials—Industry payments1Medical University of South CarolinaClinical trials1Industry payments—Merck Sharp & Dohme LLCClinical trials—Industry payments1Novartis Pharmaceuticals CorporationClinical trials—Industry payments1Pfizer Inc.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓

Research metrics need a complete publication history and a confident author match. We omit them when either check fails. Why? →

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials ↓
13companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

An office address from a public listing. This research profile has no federal registry record to draw from.

Office address

86 Jonathan Lucas Street, Hollings Cancer Center, 2nd Floor, 3rd Floor Charleston, SC 29425

From the cited public source.Collected 8 Nov 2026.View source ↗

Clinical trials

Updated 8 Nov 2026

Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:

Industry payments

Updated 8 Nov 2026

13 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

None on file yet. We only list publications we can confidently match to this person. Why? →

Online presence

Updated 8 Nov 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/abirami-sivapiragasam-md

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗

Mentions by others

where others cite or feature them
  • Other

    getcare.muschealth.org/providers/abirami-sivapiragasam-1972930998

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →getcare.muschealth.org ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 8 Nov 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Program Director

    Hematology and Oncology Fellowship Program, MUSC

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →getcare.muschealth.org ↗

Awards & honors

honors on the public record

Media & interviews

press, podcasts and appearances
  • Oncodaily feature

    "Abirami Sivapiragasam Shares a Unique Story on Her Journey in Oncology World" (ASCO-linked profile of her path to oncology)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncodaily.com ↗

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.